Disclaimer: For full disclosure, Gelatex s is a portfolio company of Climate Capital, where Jenny works as a Managing Partner.
CC Pod is not investment advice and is intended for informational and entertainment purposes only. You should do your own research and make your own independent decisions when considering any investment decision.
Subscribe to CC Pod wherever you listen to your podcasts:
In the latest episode of the Climate Capital podcast, hosted by Jenny Kan - GP of Climate Capital's Bio Fund - we had the privilege of delving into the world of Gelatex. This innovative materials technology company, led by co-founders Mari-Ann and Märt-Erik, is on a mission to revolutionize various industries by offering sustainable and versatile solutions.
TL;DL (too long; didn’t listen):
Gelatex's proprietary technology, developed in Estonia, enables the efficient production of bio-based nanofibers. These nanofibers possess unique properties that can be harnessed across a wide range of applications: from eco-friendly leather-like textiles to cultured meat, wound care, bio-based filtration materials, and tissue engineering.
Initially starting with a focus on eco-friendly textiles, Mari-Ann and Märt-Erik realized the immense potential of their nanofiber technology and made a pivotal decision to pivot in 2020. This move allowed them to explore new avenues and applications, broadening their impact on multiple industries.
Mari-Ann and Märt-Erik emphasize the importance of putting together a skilled and passionate team that aligns with their vision. Their dedication to finding the right people has been instrumental in overcoming obstacles and achieving milestones.
Looking ahead, Gelatex has ambitious plans to expand their production capabilities. They aim to establish a certified production facility, paving the way for widespread adoption of their groundbreaking materials. By continuing to disrupt industries and provide sustainable alternatives, Gelatex envisions a future where high-tech materials reshape lab-grown products.
